Mainz Biomed is a German company specialized in molecular genetics cancer diagnostic. They develop tests for clinical diagnostics in human genetics, such as the ColoAlert and PancAlert screening tests for colorectal and pancreatic cancer. The company also offers molecular genetic-based tests to detect pathogens in environments, as well as in-vitro diagnostic and research use only tests.